Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cidara Therapeutics (CDTX) Return on Assets: 2018-2025

Historic Return on Assets for Cidara Therapeutics (CDTX) over the last 8 years, with Sep 2025 value amounting to -0.25%.

  • Cidara Therapeutics' Return on Assets fell 28.00% to -0.25% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.25%, marking a year-over-year decrease of 28.00%. This contributed to the annual value of 0.00% for FY2024, which is 3.00% down from last year.
  • Per Cidara Therapeutics' latest filing, its Return on Assets stood at -0.25% for Q3 2025, which was down 84.07% from -0.14% recorded in Q2 2025.
  • Cidara Therapeutics' 5-year Return on Assets high stood at 0.19% for Q4 2023, and its period low was -1.52% during Q2 2022.
  • In the last 3 years, Cidara Therapeutics' Return on Assets had a median value of 0.00% in 2024 and averaged -0.02%.
  • As far as peak fluctuations go, Cidara Therapeutics' Return on Assets crashed by 80bps in 2021, and later soared by 170bps in 2023.
  • Over the past 5 years, Cidara Therapeutics' Return on Assets (Quarterly) stood at -0.67% in 2021, then increased by 4bps to -0.64% in 2022, then skyrocketed by 83bps to 0.19% in 2023, then declined by 19bps to 0.00% in 2024, then fell by 28bps to -0.25% in 2025.
  • Its Return on Assets stands at -0.25% for Q3 2025, versus -0.14% for Q2 2025 and -0.10% for Q1 2025.